SIRT1 and metabolic dysfunction-associated steatohepatitis: It was demonstrated on a mouse model that miR-29a inhibits glycogen synthase kinase 3 beta to repress sirtuin 1 (SIRT1)-mediated mitochondrial biogenesis and improve methionine–choline-deficient diet-induced NASH in mice.